Completed NA INTERVENTIONAL 2-arm NCT00978263

Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes

An Efficacy and Safety Comparison of Basal Insulin and OADs in Newly Diagnosed Type 2 Diabetes After Short-term Intensive Insulin Therapy

Sponsor: Chongqing Medical University

Conditions Diabetes

Interventions Glargine metformin-based Oral Antidiabetic Drugs

Updated 6 times since 2017 Last updated: Feb 4, 2013 Started: Feb 28, 2009 Primary completion: Dec 31, 2011 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00978263, this NA trial focuses on Diabetes and remains completed. Sponsored by Chongqing Medical University, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chongqing Medical University

Data source: Chongqing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China